High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease

Thirty-eight patients with previously treated Hodgkin's disease were given high dose combination chemotherapy using melphalan and BCNU and autologous bone marrow transplantation. In 25 patients etoposide was added in conventional dosage. During the course of the study the dose of melphalan was...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 1989-04, Vol.59 (4), p.631-635
Hauptverfasser:	ZULIAN, G. B, SELBY, P, MILAN, S, NANDI, A, GORE, M, FORGESON, G, PERREN, T. J, MCELWAIN, T. J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Bone Marrow Transplantation Carmustine - administration & dosage Carmustine - adverse effects Combined Modality Therapy Etoposide - administration & dosage Etoposide - adverse effects Female Hematologic and hematopoietic diseases Hodgkin Disease - drug therapy Hodgkin Disease - therapy Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Melphalan - administration & dosage Melphalan - adverse effects Middle Aged
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!